| Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease V Srikanth, A Maczurek, T Phan, M Steele, B Westcott, D Juskiw, G Münch Neurobiology of aging 32 (5), 763-777, 2011 | 608 | 2011 |
| Brain atrophy in type 2 diabetes: regional distribution and influence on cognition C Moran, TG Phan, J Chen, L Blizzard, R Beare, A Venn, G Münch, ... Diabetes care 36 (12), 4036-4042, 2013 | 542 | 2013 |
| Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds L Zhang, AS Ravipati, SR Koyyalamudi, SC Jeong, N Reddy, PT Smith, ... Journal of agricultural and food chemistry 59 (23), 12361-12367, 2011 | 468 | 2011 |
| Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease A Maczurek, K Hager, M Kenklies, M Sharman, R Martins, J Engel, ... Advanced drug delivery reviews 60 (13-14), 1463-1470, 2008 | 422 | 2008 |
| Advanced glycation endproducts in ageing and Alzheimer's disease G Münch, J Thome, P Foley, R Schinzel, P Riederer Brain research reviews 23 (1-2), 134-143, 1997 | 419 | 1997 |
| Alzheimer's disease–synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts G Münch, R Schinzel, C Loske, A Wong, N Durany, JJ Li, H Vlassara, ... Journal of neural transmission 105, 439-461, 1998 | 405 | 1998 |
| Lipoic acid as a novel treatment for Alzheimer's disease and related dementias L Holmquist, G Stuchbury, K Berbaum, S Muscat, S Young, K Hager, ... Pharmacology & therapeutics 113 (1), 154-164, 2007 | 392 | 2007 |
| Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA G Münch, R Keis, A Weßels, P Riederer, U Bahner, A Heidland, T Niwa, ... Walter de Gruyter, Berlin/New York 35 (9), 669-678, 1997 | 386 | 1997 |
| Antioxidant and anti-inflammatory activities of selected Chinese medicinal plants and their relation with antioxidant content AS Ravipati, L Zhang, SR Koyyalamudi, SC Jeong, N Reddy, J Bartlett, ... BMC complementary and alternative medicine 12, 1-14, 2012 | 351 | 2012 |
| Alpha-lipoic acid as a new treatment option for Azheimer type dementia K Hager, A Marahrens, M Kenklies, P Riederer, G Münch Archives of gerontology and geriatrics 32 (3), 275-282, 2001 | 281 | 2001 |
| Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment N Ahmed, U Ahmed, PJ Thornalley, K Hager, G Fleischer, G Münch Journal of neurochemistry 92 (2), 255-263, 2005 | 280 | 2005 |
| Aberrant expression of NOS isoforms in Alzheimer’s disease is structurally related to nitrotyrosine formation HJ Lüth, G Münch, T Arendt Brain research 953 (1-2), 135-143, 2002 | 279 | 2002 |
| High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-κB activation and cytokine expression A Neumann, R Schinzel, D Palm, P Riederer, G Münch FEBS letters 453 (3), 283-287, 1999 | 271 | 1999 |
| Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics A Schmitt, J Schmitt, G Münch, J Gasic-Milencovic Analytical biochemistry 338 (2), 201-215, 2005 | 268 | 2005 |
| Crosslinking of α-synuclein by advanced glycation endproducts—an early pathophysiological step in Lewy body formation? G Münch, HJ Lüth, A Wong, T Arendt, E Hirsch, R Ravid, P Riederer Journal of chemical neuroanatomy 20 (3-4), 253-257, 2000 | 267 | 2000 |
| α-Lipoic acid as a new treatment option for Alzheimer’s disease—A 48 months follow-up analysis K Hager, M Kenklies, J McAfoose, J Engel, G Münch Neuropsychiatric disorders an integrative approach, 189-193, 2007 | 247 | 2007 |
| Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease R Balez, N Steiner, M Engel, SS Muñoz, JS Lum, Y Wu, D Wang, ... Scientific reports 6 (1), 31450, 2016 | 240 | 2016 |
| Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide G Münch, S Mayer, J Michaelis, AR Hipkiss, P Riederer, R Müller, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1360 (1), 17-29, 1997 | 235 | 1997 |
| Amyloid β-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists DA Butterfield, S Griffin, G Munch, GM Pasinetti Journal of Alzheimer's Disease 4 (3), 193-201, 2002 | 226 | 2002 |
| Age-and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains HJ Lüth, V Ogunlade, B Kuhla, R Kientsch-Engel, P Stahl, J Webster, ... Cerebral cortex 15 (2), 211-220, 2005 | 223 | 2005 |
